Authors : Hong Leea1 ,
Sang Hoon Jeonga1 ,
Yong-Wook Baekb1 ,
Hyejin Leea,
Jason K. Sac,
Ji Yoon Leec,
Yu-Seon Leea,
Yoon Jeong Nama,
Jaeyoung Kima ,
Jonghoon Kimd,
Jin Young Choia,
Su A. Parka,
Je Hyeong Kime,
Yoon Hee Parkb,
Jungyun Limb,
Young-Hee Kimb,
Younghee Kime,
Eun-Kee Parkf,
Cherry Kimg,
Ju-Han Leeh
Author Affiliations
a. Medical Science Research Center, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Gyeonggi, 15355, Republic of Korea
b. Humidifier Disinfectant Health Center, National Institute of Environmental Research, Incheon, 22689, Republic of Korea
c. Department of Biomedical Sciences, Korea University College of Medicine, Seoul, 02841, Republic of Korea
d. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, 06531, Republic of Korea
e. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Gyeonggi, 15355, Republic of Korea
f. Department of Medical Humanities and Social Medicine, College of Medicine, Kosin University, Busan, 49267, Republic of Korea
g. Department of Radiology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Gyeonggi, 15355, Republic of Korea
h. Department of Pathology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Gyeonggi, 15355, Republic of Korea
Keyword : Lung carcinogenesis, PHMG-p, TAK1, Necroptosis, MAPK signaling, Somatic mutation
Abstract
Polyhexamethylene guanidine (PHMG) is widely utilized in personal hygiene products due to its bactericidal, non-volatile, and hydrophilic properties. However, the long-term toxic effects and underlying mechanisms associated with respiratory exposure to the commonly used form, PHMG phosphate (PHMG-p), are still insufficiently understood. This study aims to elucidate the types of pulmonary lesions and the incidence of lung cancer associated with varying concentrations of PHMG-p and observation periods, along with the molecular mechanisms underlying this relationship. To assess these effects, CT scans and pathological analyses were conducted for up to 54 weeks following initial exposure to PHMG-p. Furthermore, to investigate the underlying causes of pulmonary toxicity, TGF-beta-activated kinase 1 was identified as a PHMG-p-binding protein, and its associated signaling pathways, including necroptosis, apoptosis, and MKK7, were explored. Somatic mutational signature, and gene ontology (GO) analyses were performed to investigate the genetic characteristics of PHMG-p-induced lung carcinogenesis. PHMG-p exposure led to somatic mutations in lung cancer-related genes, including TP53, SOS1, KMT2D, MDM2, ERBB2, SETD2, MET, ARID1A, RBM10, and CDKN2A as well as in genes such as RAB31, WASHC1, DDX11, ECD, STAB2, MUC2, and MUC5AC. The mutated genes were primarily associated with impaired DNA repair mechanisms. GO analysis highlighted the activation of pathways related to cell cycle checkpoints, necroptosis, MAPK, and idiopathic pulmonary fibrosis, while also revealing the suppression of signaling pathways associated with natural killer cells, GADD45, LXR/RXR activation, and IL-15 production. Gain-of-function experiments confirmed the oncogenic roles of PLAU and HMGA2, as well as the tumor-suppressive functions of TBX4 and GPX3. These findings suggest that PHMG-p activates necroptosis and MAPK signaling, increases the frequency of somatic mutations, and inhibits apoptosis, thus fostering an environment conducive to carcinogenesis. This underscores the importance of understanding the potential health risks associated with PHMG-p exposure and provides insights for future research and regulatory considerations regarding the safety of personal hygiene products.